Miguel Juan
García González
Profesor/a Asociado/a en CC. de la Salud
Hospital Universitario de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Cruces (5)
2022
-
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342
2017
-
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Transplant International, Vol. 30, Núm. 10, pp. 1041-1050
2009
-
Pamidronate in the prevention of bone loss after liver transplantation: A randomized controlled trial
Transplant International, Vol. 22, Núm. 2, pp. 198-206
2005
-
An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: A comparison of dual vs. triple drug therapy
Liver Transplantation, Vol. 11, Núm. 5, pp. 515-524
2002
-
Tacrolimus is effective in both dual and triple regimens after liver transplantation
Transplantation Proceedings